Knowstox

Fundamentals snapshot

Oscar Health, Inc.

OSCR · NYQ · Healthcare · Healthcare Plans

Current price

$31.89

52-week range

$10.69 - $35.01

Market cap

$9.84B

One-glance verdict

Valued differently

We value banks a different way

We don't put a cash-flow fair value on banks and insurers. For these companies the reported 'cash flow' is really just money moving between loans, deposits and trades — not the leftover profit the owners could actually pocket — so the usual method would print a misleading number.

Balance sheet

Healthy

-23.85x Concerning

Net cash $8.07B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Oscar Health, Inc.

Oscar Health, Inc. is a company that offers health insurance plans to individuals, families, and small businesses, with much of its money coming from the premiums people pay for these plans. This matters because their success depends on signing up enough people and managing the costs of healthcare services for those members. They also have technology platforms to help other healthcare companies run more smoothly.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-507.71M FY2024 Q4 $340.00M FY2025 Q1 $869.52M FY2025 Q2 $499.79M FY2025 Q3 $-973.66M FY2025 Q4 $662.84M FY2026 Q1 $2.61B FY2026 Q2 $2.08B
Revenue $4.88B
Net income $361.81M
Diluted EPS 1.10
Operating cash flow $2.09B
Free cash flow $2.08B
Revenue $4.65B
Net income $679.00M
Diluted EPS 2.07
Operating cash flow $2.62B
Free cash flow $2.61B
Revenue $2.81B
Net income $-352.61M
Diluted EPS -1.19
Operating cash flow $671.90M
Free cash flow $662.84M
Revenue $2.99B
Net income $-137.45M
Diluted EPS -0.53
Operating cash flow $-964.66M
Free cash flow $-973.66M
Revenue $2.86B
Net income $-228.36M
Diluted EPS -0.89
Operating cash flow $509.07M
Free cash flow $499.79M
Revenue $3.05B
Net income $275.27M
Diluted EPS 0.92
Operating cash flow $878.54M
Free cash flow $869.52M
Revenue $2.39B
Net income $-153.55M
Diluted EPS -0.50
Operating cash flow $346.82M
Free cash flow $340.00M
Revenue $2.42B
Net income $-54.60M
Diluted EPS -0.22
Operating cash flow $-500.14M
Free cash flow $-507.71M

Is it cheap or expensive?

We value banks and insurers a different way

For a bank or insurer, the "free cash flow" shown on its statements is mostly money flowing through loans, deposits and trades — not the leftover profit the owners could actually keep, which is what this kind of valuation needs. Running that through the usual method would spit out a meaningless number, so we leave the cash-flow fair value out here rather than show you something misleading.

Valued differently

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Is it drowning in debt?

Healthy

Net cash $8.1B - more cash than debt. Interest coverage -23.8x.

Net debt $-8.07B
Interest coverage -23.85x

Oscar Health, Inc.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Healthy
Worse cushion Baseline Better cushion
OSCR BASELINE Oscar Health, Inc.

Total debt $482.10M Interest coverage -23.85x This is the baseline the peer rows are being compared against.

Total debt $3.95B Interest coverage 4.07x This peer still has a real interest-payment cushion, while OSCR does not.

Total debt $330.50M Interest coverage 0.93x This peer still has a real interest-payment cushion, while OSCR does not.

Total debt $33.45M Interest coverage -64.32x Neither company has much profit cushion over interest right now.

What you should know

The case for and against OSCR

3 Rewards 0 Risks

Rewards

  • Revenue grew 30.9% last year.
  • Returns 34.3% on equity, ahead of 80% of its peers.
  • Free cash flow was positive in 4/10 years.

Risks

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
24.72x
Forward P/E
14.36x
P/B
4.79x
P/S
0.64x
EV/EBITDA
2.68x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
20.2%
Operating margin
8.0%
Net margin
3.6%
ROE
34.3%
ROA
4.5%

Health

Liquidity and balance-sheet strength

Debt / equity
0.23x
Current ratio
1.08x
Quick ratio
1.05x
Total debt
$482.10M
Total cash
$8.56B

Growth

How the business has been compounding

Revenue TTM
$15.32B
Revenue 5Y CAGR
58.8%
EPS TTM
1.29
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$4.42B
Free CF TTM
$1.06B
FCF margin
6.9%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—